| Not Yet Recruiting | Korea Post Marketing Surveillance (PMS) Study of Talzenna® Breast Neoplasms | — | 2027-06-01 |
| Not Yet Recruiting | A Study to Learn More About Tukysa Once it is Out in the Korean Market HER2-positive Locally Advanced Unresectable, Metastatic Breast Cancer | — | 2027-01-01 |
| Not Yet Recruiting | A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea Migraine With or Without Aura | — | 2026-10-01 |
| Not Yet Recruiting | A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or Wi Healthy | Phase 1 | 2026-09-15 |
| Recruiting | Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherap Small Cell Lung Cancer, Small Cell Lung Cancer ( SCLC ), Transformed Small Cell Lung Cancer | Phase 2 | 2026-05-15 |
| Not Yet Recruiting | An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients Fro Colorectal Cancer | — | 2026-05-01 |
| Not Yet Recruiting | Describing Treatment Patterns and Creating an Updated Treatment Flow in an Ulcerative Colitis Population Ulcerative Colitis | — | 2026-04-30 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophag Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma, Metastatic Gastric Cancer, Gastroesophageal Junction Cancer | Phase 2 / Phase 3 | 2026-04-28 |
| Not Yet Recruiting | A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function Healthy | Phase 1 | 2026-04-15 |
| Not Yet Recruiting | A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the B Healthy | Phase 1 | 2026-04-13 |
| Not Yet Recruiting | A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lym Lyme Disease | Phase 3 | 2026-04-10 |
| Not Yet Recruiting | Phase 1 Study of PF-08046033 in Advanced Solid Tumors Non-Small-Cell Lung, Esophageal Cancer, Cutaneous Melanoma | Phase 1 | 2026-04-01 |
| Not Yet Recruiting | Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanc Carcinoma, Non-Small-Cell Lung, Lung Cancer (NSCLC) | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Healthy | Phase 1 | 2026-04-01 |
| Not Yet Recruiting | Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset Respiratory Syncytial Virus Infections | — | 2026-04-01 |
| Not Yet Recruiting | A Study to Learn About the Effect of Study Medicine Called PF-08653944 on How Quickly the Stomach Empties Its Obesity, Overweight and/or Obesity, Overweight | Phase 1 | 2026-03-31 |
| Not Yet Recruiting | A Retrospective Observational Study of Epidemiology and Outcomes in Transthyretin Amyloid Cardiomyopathy in Ge ATTR-CM (Transthyretin Amyloid Cardiomyopathy) | — | 2026-03-31 |
| Not Yet Recruiting | A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Coliti Colitis, Ulcerative | Phase 2 | 2026-03-31 |
| Not Yet Recruiting | An Observational Study to Learn About Velsipity After Long Term Use in Patients With Ulcerative Colitis Ulcerative Colitis (UC) | — | 2026-03-31 |
| Not Yet Recruiting | A Real World Study of Elranatamab in Patients With RR Multiple Myeloma in Taiwan Refractory Multiple Myeloma (RRMM) | — | 2026-03-31 |
| Not Yet Recruiting | A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions Healthy | Phase 1 | 2026-03-27 |
| Not Yet Recruiting | An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers Advanced Malignancies, Advanced Cancer | Phase 1 | 2026-03-26 |
| Not Yet Recruiting | A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Ja Infectious Diseases | — | 2026-03-15 |
| Recruiting | Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Ot Carcinoma, Renal Cell, Advanced Renal Cell Carcinoma, Renal Cancer | Phase 1 / Phase 2 | 2026-03-12 |
| Recruiting | Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothel Urothelial Cancer, Advanced/Metastatic Urothelial Cancer, Urothelial Carcinoma | Phase 1 / Phase 2 | 2026-03-11 |
| Active Not Recruiting | A Study to Learn About How the Body Processes the Study Medicine Called PF-07328948 in Healthy Chinese Adults Healthy Participant | Phase 1 | 2026-03-02 |
| Recruiting | A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabet Obesity, Overweight and/or Obesity, Overweight | Phase 3 | 2026-02-24 |
| Recruiting | A Study to Learn About mRNA Vaccines Against Influenza in Adults Healthy Adults | Phase 2 | 2026-02-23 |
| Not Yet Recruiting | Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the US Alopecia Areata | — | 2026-02-16 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstruc Moderate to Severe Chronic Obstructive Pulmonary Disease | Phase 2 / Phase 3 | 2026-02-11 |
| Recruiting | A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweigh Overweight, Obesity, Healthy | Phase 1 | 2026-02-04 |
| Recruiting | Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Advanced/Metastatic Non-Small Cell Lung Cancer, Carcinoma, Non-Small Cell Lung, Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2026-01-30 |
| Not Yet Recruiting | A Real-world Study of the First Treatment and Outcomes of Patients With Advanced or Metastatic Bladder Cancer Metastatic Urothelial Carcinoma, Urothelial Cancer, Urothelial Carcinoma | — | 2026-01-30 |
| Recruiting | A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function Renal Impairment, Healthy | Phase 1 | 2026-01-28 |
| Active Not Recruiting | A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia Pneumonia | — | 2026-01-21 |
| Recruiting | Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had I Atopic Dermatitis, Atopic Dermatitis, Unspecified, Dermatitis, Atopic | — | 2026-01-13 |
| Recruiting | Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemother Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung | Phase 3 | 2026-01-06 |
| Active Not Recruiting | A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine) Healthy Adult Participants | Phase 1 | 2026-01-02 |
| Recruiting | A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Live Hepatic Impairment, Healthy | Phase 1 | 2025-12-29 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumor Advanced Breast Cancer, Metastatic Breast Cancer (HR+/ HER2-), Colorectal Cancer | Phase 1 | 2025-12-16 |
| Recruiting | Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy Intestinal Neoplasms, Gastrointestinal Neoplasms, Digestive System Neoplasms | Phase 3 | 2025-12-11 |
| Recruiting | A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the B Healthy | Phase 1 | 2025-12-11 |
| Recruiting | A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older Clostridioides Difficile Associated Disease | Phase 3 | 2025-12-10 |
| Recruiting | Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemothera Small Cell Lung Cancer (SCLC) | Phase 2 / Phase 3 | 2025-12-09 |
| Recruiting | A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Sever Atopic Dermatitis | Phase 3 | 2025-12-02 |
| Recruiting | Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combinatio Carcinoma, Hepatocellular, Hepatocellular Cancer, Hepatocellular Carcinoma | Phase 1 / Phase 2 | 2025-12-01 |
| Active Not Recruiting | Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants Respiratory Syncytial Virus (RSV) | — | 2025-12-01 |
| Recruiting | A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Healthy Volunteer | Phase 1 | 2025-11-24 |
| Active Not Recruiting | A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema Atopic Dermatitis, Eczema, Atopic | Phase 2 | 2025-11-20 |
| Active Not Recruiting | A Study to Learn About Different Dosing Schedules of a Lyme Disease Vaccine in Healthy Adults Lyme Borreliosis | Phase 3 | 2025-11-19 |
| Recruiting | A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver F Healthy Participants | Phase 1 | 2025-11-18 |
| Active Not Recruiting | Consistency of Response With Rimegepant in Acute Treatment of Migraine Migraine | — | 2025-11-15 |
| Recruiting | A Study to Learn How Different Forms of the Study Medicine Called Prazosin Are Taken up Into the Blood in Heal Healthy | Phase 1 | 2025-11-14 |
| Recruiting | A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Hidradenitis Suppurativa | Phase 2 | 2025-11-13 |
| Recruiting | A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market Pneumococcal Immunization, Safety | — | 2025-11-13 |
| Recruiting | A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Pulmonary Hypertension | Phase 2 | 2025-11-10 |
| Recruiting | A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer Non-muscle Invasive Bladder Cancer | Phase 1 | 2025-11-06 |
| Active Not Recruiting | A Study to Learn if a Medicine That Reduces Stomach Acid Affects the Blood Level of Study Medicine PF-08049820 Healthy Adults | Phase 1 | 2025-11-03 |
| Active Not Recruiting | A Study to Learn About the Study Medicine -Hympavzi in Congenital Hemophilia Patients Without Inhibitors in Ja Hemophilia A or B | — | 2025-10-30 |
| Recruiting | A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults. Chronic Spontaneous Urticaria | Phase 2 | 2025-10-30 |
| Active Not Recruiting | A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly COVID-19 | — | 2025-10-27 |
| Completed | A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up Into the Blood in Healthy Chinese Adul Healthy Participant | Phase 1 | 2025-10-16 |
| Completed | A Study to Understand What the Body Does to the Study Medicine Called PF-07248144 When Taken by Healthy Adults Healthy Adult Participants | Phase 1 | 2025-10-13 |
| Recruiting | Study About Whether Atirmociclib/PF-07220060 Proportionally Increases Exposure as Dose Increases in Healthy Pa Healthy Volunteer | Phase 1 | 2025-10-08 |
| Recruiting | A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Cau Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 2 / Phase 3 | 2025-10-03 |
| Active Not Recruiting | A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medic Atopic Dermatitis | Phase 1 | 2025-10-03 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Carcinoma | Phase 3 | 2025-09-29 |
| Recruiting | This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enza Metastatic Castration Sensitive Prostate Cancer (mCSPC), Hormone Sensitive Prostate Cancer, Prostate Cancer | Phase 3 | 2025-09-28 |
| Completed | A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processe Healthy Adults | Phase 1 | 2025-09-22 |
| Completed | A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes t Healthy Adults | Phase 1 | 2025-09-18 |
| Withdrawn | A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants Migraine | Phase 3 | 2025-09-15 |
| Recruiting | A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areat Severe Alopecia Areata | Phase 3 | 2025-09-10 |
| Completed | A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstrea Atopic Dermatitis | Phase 1 | 2025-09-05 |
| Completed | A Study to Understand How the Body Processes [14C]PF-07104091 in Healthy Participants Healthy Adults | Phase 1 | 2025-08-28 |
| Recruiting | A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice. Severe Alopecia Areata | — | 2025-08-27 |
| Recruiting | BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies Healthy | Phase 3 | 2025-08-25 |
| Completed | Atrial Fibrillation Data Linkage Non-Interventional Study Atrial Fibrillation | — | 2025-08-21 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors Advanced/Metastatic Solid Tumors, Bladder Cancer, Urothelial Carcinoma | Phase 1 | 2025-08-20 |
| Not Yet Recruiting | A Study to Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Livi Coronavirus Disease 2019 (COVID-19) | — | 2025-08-18 |
| Withdrawn | A Study on 2 Different Combination Tablets of Nirmatrelvir Plus Ritonavir to Compare Them With Marketed Paxlov Biological Availability, Healthy Participants | Phase 1 | 2025-08-15 |
| Completed | A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants Healthy Participant | Phase 1 | 2025-08-14 |
| Recruiting | A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the B Healthy | Phase 1 | 2025-08-13 |
| Active Not Recruiting | STudy of Real World vaccinE Effectiveness of maTernal RSVpreF vaccinatiON Against Respiratory Syncytial Virus Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus, Lower Respiratory Tract Disease | — | 2025-08-11 |
| Recruiting | A Study to Learn About a Vaccine Against E Coli in Healthy Adults Healthy Participants | Phase 1 | 2025-08-11 |
| Recruiting | A Study to Learn How the Study Medicine Called Etrasimod is Taken up Into Blood and Breastmilk of Healthy Brea Healthy Participant | Phase 1 | 2025-08-07 |
| Terminated | A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnut Healthy Volunteers | Phase 1 | 2025-08-05 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR Breast Cancer | Phase 3 | 2025-08-05 |
| Recruiting | A Study to Learn About Medicine Called Ritlecitinib in Children Aged Between 6 to 12 Years With Severe Alopeci Severe Alopecia Areata | Phase 3 | 2025-07-31 |
| Recruiting | A Study of the Medicine Called Abrocitinib in Children 6 to Less Than 12 Years of Age With Moderate-to-Severe Eczema | Phase 3 | 2025-07-24 |
| Recruiting | This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizuma Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | Phase 3 | 2025-07-23 |
| Active Not Recruiting | A Study to Learn About How a New Pneumococcal Vaccine Works in Adults Streptococcus Pneumoniae | Phase 1 | 2025-07-22 |
| Completed | A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensi Metastatic Castration Sensitive Prostate Cancer (mCSPC), Cancer of the Prostate, Prostate Neoplasms | — | 2025-07-21 |
| Completed | A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the B Healthy Adults | Phase 1 | 2025-07-15 |
| Recruiting | A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromi COVID-19 Infection | Phase 3 | 2025-07-14 |
| Active Not Recruiting | A Study to Learn About the Safety of TALZENNA in People With Prostate Cancer. Prostate Cancer | — | 2025-07-11 |
| Completed | A Study to Learn About How Safe and Effective is 20vPnC and 13vPnC Vaccines in Chinese Adults Pneumococcal Disease | Phase 1 | 2025-07-06 |
| Active Not Recruiting | A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out. Carcinoma, Non-Small-Cell Lung | — | 2025-07-04 |
| Completed | A Study to Understand the Patients Confirmed to Have Advanced or Metastatic Breast Cancer and Receiving Palboc Advanced or Metastatic Breast Cancer | — | 2025-06-30 |
| Recruiting | A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer Breast Cancer, Breast Neoplasms | Phase 1 / Phase 2 | 2025-06-30 |
| Completed | A Study to Learn How the Study Medicine Called [14C]PF-07054894 is Processed by the Body Healthy | Phase 1 | 2025-06-20 |
| Active Not Recruiting | A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 Are Tolerated and Act in the B Healthy | Phase 1 | 2025-06-20 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF) Heart Failure | Phase 2 | 2025-06-19 |
| Active Not Recruiting | A Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant Pneumococcal Disease | Phase 1 | 2025-06-15 |
| Active Not Recruiting | Korean Post Marketing Surveillance for ELREXFIO (Elranatamab). Multiple Myeloma | — | 2025-06-05 |
| Completed | A Study to Understand How the Study Medicine (PF-07976016) is Processed and Eliminated in Healthy Men Healthy Male Volunteers | Phase 1 | 2025-06-04 |
| Active Not Recruiting | SPECIAL INVESTIGATION FOR ABRYSVO IN INDIVIDUALS AGED 60 YEARS OR OLDER Respiratory Syncytial Virus Infection | — | 2025-05-27 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma Asthma | Phase 2 | 2025-05-20 |
| Recruiting | A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migrai Acute Treatment of Migraine | Phase 1 | 2025-05-16 |
| Withdrawn | A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Vari Non-small Cell Lung Cancer, Metastatic Colorectal Cancer, Metastatic Breast Cancer | — | 2025-05-16 |
| Recruiting | A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemo Severe Hemophilia A | Phase 1 | 2025-05-13 |
| Active Not Recruiting | A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers Peripheral T Cell Lymphoma, Diffuse Large B-cell Lymphoma, Classical Hodgkin Lymphoma | Phase 1 | 2025-05-08 |
| Completed | Real World-clinical Outcomes of Tucatinib, Trastuzumab, and Capecitabine Following Trastuzumab Deruxtecan (T-D Metastatic HER2+ Advanced Breast Cancer | — | 2025-05-07 |
| Recruiting | Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer Cervical Cancer | Phase 4 | 2025-05-07 |
| Active Not Recruiting | A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies Carcinoma, Non Small Cell Lung, Carcinoma, Pancreatic Ductal, Malignant Melanoma | Phase 1 | 2025-05-06 |
| Terminated | A Study to Learn About the Study Medicine Called PF-08046031 in Advanced Melanoma and Other Solid Tumors Malignant Melanoma, Melanoma, Metastatic Melanoma | Phase 1 | 2025-05-01 |
| Withdrawn | A Study to Learn How Different Tablets of the Study Medicine Mevrometostat Are Taken up Into the Blood in Heal Healthy | Phase 1 | 2025-04-28 |
| Completed | Secondary Databased Post-marketing Surveillance Study of BNT162b2 COVID-19, SARS-CoV-2 | — | 2025-04-23 |
| Active Not Recruiting | A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 an COVID-19 SARS-CoV-2 Infection, COVID-19, COVID-19 Infection | — | 2025-04-16 |
| Recruiting | A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protectio RSV Infection | Phase 3 | 2025-04-16 |
| Completed | A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions. COVID-19 | — | 2025-04-15 |
| Active Not Recruiting | A Study to Learn About the Safety of TALZENNA for the Treatment of Breast Cancer Breast Cancer | — | 2025-04-12 |
| Completed | A Study to Evaluate the Safety and Immunogenicity of RSVpreF Coadministered With Herpes Zoster Vaccine in Adul Respiratory Syncytial Virus (RSV) | Phase 3 | 2025-04-04 |
| Completed | A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken Healthy Participants | Phase 1 | 2025-04-03 |
| Recruiting | A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata Alopecia Areata | Phase 3 | 2025-04-01 |
| Completed | A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060 Healthy Adults | Phase 1 | 2025-03-21 |
| Completed | A Study to Learn if Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the O Healthy Adults | Phase 1 | 2025-03-19 |
| Withdrawn | Patient Interview Study to Explore the Impact of Gene Therapy in Hemophilia A & B Hemophilia A, Hemophilia B | — | 2025-03-17 |
| Terminated | Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and Overweight, Obesity | Phase 1 | 2025-03-13 |
| Recruiting | A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine | Phase 3 | 2025-03-11 |
| Completed | A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants Healthy | Phase 1 | 2025-02-24 |
| Active Not Recruiting | Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Respiratory Syncytial Viruses | — | 2025-02-24 |
| Terminated | A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the B Healthy | Phase 1 | 2025-02-11 |
| Completed | A Study to Learn About How Different Forms of Study Medicine PF-07248144 Are Taken Up Into the Blood in Health Healthy Adults | Phase 1 | 2025-02-04 |
| Completed | A Study to Learn About the Medicine Called Ritlecitinib in Adults With Severe Alopecia Areata in Real-world Se Severe Alopecia Areata | — | 2025-02-03 |
| Completed | RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study Lymphoma | — | 2025-01-31 |
| Recruiting | A Study to Learn About Somatrogon in Patients With Pediatric Growth Hormone Deficiency (p GHD) in India. Dwarfism, Pituitary | — | 2025-01-30 |
| Recruiting | A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathie Dermatomyositis, Polymyositis | Phase 3 | 2025-01-22 |
| Completed | A Study to Understand About the Study Medicine Palbociclib in Breast Cancer Patients After it is Out in the Ja Breast Neoplasms | — | 2025-01-21 |
| Active Not Recruiting | A Study to Learn About How Well the Prevnar 20 Vaccine Works for Pneumonia in People Who Are 65 Years and Olde Community-Acquired Pneumonia (CAP) | — | 2025-01-20 |
| Recruiting | Analysis of the Effectiveness and Safety of Lorlatinib in Untreated ALK-Positive NSCLC Patients in a French Re ALK+ Non-Small-Cell Lung Carcinoma | N/A | 2025-01-20 |
| Recruiting | A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML). Chronic Leukemia Myelogenous | — | 2025-01-20 |
| Recruiting | Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Receiv Breast Cancer | Phase 3 | 2025-01-06 |
| Completed | A Study to Learn More About the Study Medicine PF-07275315 in Healthy Chinese Adult Participants Healthy | Phase 1 | 2025-01-06 |
| Completed | A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Healthy | Phase 1 | 2024-12-23 |
| Completed | A Study to Compare Two Forms of Study Medicine Tafamidis in the Blood in Healthy Adults Healthy | Phase 1 | 2024-12-20 |
| Completed | A Study to Learn if the Study Medicine Called Itraconazole and if Food Changes How the Body Processes the Othe Healthy | Phase 1 | 2024-12-11 |
| Active Not Recruiting | A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | 2024-12-10 |
| Completed | A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity Obesity | Phase 2 | 2024-12-09 |
| Recruiting | A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who COVID-19 SARS-CoV-2 Infection | Phase 3 | 2024-12-08 |
| Completed | A Study to Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of H Healthy Participants | Phase 1 | 2024-12-03 |
| Active Not Recruiting | A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the B Healthy | Phase 1 | 2024-11-27 |
| Terminated | Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine COVID-19 | — | 2024-11-25 |
| Active Not Recruiting | A Study to Learn About the Safety of PREVENAR 20 Vaccine in Infants Aged Between Two to Six Months Pneumococcal Disease | — | 2024-11-25 |
| Completed | A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acn Acne Vulgaris | Phase 1 | 2024-11-22 |
| Completed | A Study to Learn About if the Study Medicine Called Ibuzatrelvir Changes How the Body Process the Other Medici SARS-CoV-2 Infections | Phase 1 | 2024-11-22 |
| Recruiting | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine Migraine | Phase 3 | 2024-11-15 |
| Terminated | A Study to Learn About PF-07921585 Alone or With Other Anti-cancer Medicines in People With Cancer Non Small Cell Lung Cancer, Bladder Cancer, Renal Cell Carcinoma | Phase 1 | 2024-11-11 |
| Active Not Recruiting | A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia. Acute Lymphocytic Leukemia | — | 2024-11-07 |
| Recruiting | FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients Healthy Participants, Atopic Dermatitis | Phase 1 | 2024-11-05 |
| Completed | A Study to Learn How Different Forms of the Study Medicine Called PF-07976016 Are Taken Up Into the Blood in H Healthy Volunteers | Phase 1 | 2024-11-05 |
| Completed | A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who COVID-19 (Coronavirus Disease 2019) | — | 2024-10-31 |
| Completed | A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Med Healthy | Phase 1 | 2024-10-28 |
| Recruiting | A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Ca Metastatic Castration-Resistant Prostate Cancer | Phase 3 | 2024-10-22 |
| Recruiting | A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who W Metastatic Castrate Resistant Prostate Cancer (mCRPC) | Phase 3 | 2024-10-21 |
| Completed | A Study to Learn How Different Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood in Heal Healthy | Phase 1 | 2024-10-16 |
| Active Not Recruiting | Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran) COVID-19 Vaccination | — | 2024-10-11 |
| Completed | Comparison of Patient-reported Outcomes for Rimegepant and Triptans in the 2023 US National Health and Wellnes Migraine | — | 2024-10-10 |
| Completed | A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Older Adults in Korea Respiratory Syncytial Virus | Phase 3 | 2024-10-07 |
| Active Not Recruiting | ATTR-CM: A Multi-country, Non-interventional Disease Registry Transthyretin Amyloid Cardiopathy | — | 2024-10-01 |
| Completed | SPECIAL INVESTIGATION FOR ABRYSVO IN PREGNANT WOMEN AND INFANTS Respiratory Tract Infection | — | 2024-10-01 |
| Withdrawn | A Study to Learn About Dacomitnib in Patients With Non-small Cell Lung Cancer Which Has Spread to the Brain. Carcinoma, Non-Small-Cell Lung | — | 2024-09-30 |
| Completed | A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adult Healthy Participants | Phase 1 | 2024-09-27 |
| Recruiting | A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Ho Gram-negative Bacterial Infection | Phase 2 | 2024-09-25 |
| Recruiting | An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis Colitis, Ulcerative | — | 2024-09-17 |
| Completed | A Study to Learn How Renal Impairment Affects the Pharmacokinetics of PF-07817883. COVID-19 | Phase 1 | 2024-09-10 |
| Terminated | A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Neoplasms, Non-small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2024-09-06 |
| Completed | A Study to Learn How the Medicine Called [14C] PF-06821497 is Taken up Into and Removed From the Body. Healthy Participants | Phase 1 | 2024-08-30 |
| Completed | A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How Obesity | Phase 1 | 2024-08-28 |
| Completed | A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma | — | 2024-08-26 |
| Active Not Recruiting | Impact and Effectiveness of ABRYSVO® Vaccination During Pregnancy Respiratory Syncytial Virus, Respiratory Tract Diseases | — | 2024-08-26 |
| Completed | A Study to Learn How Different Amounts of the Study Medicine Danuglipron Are Taken up Into the Blood in Otherw Obesity | Phase 1 | 2024-08-23 |
| Completed | A Study to Learn About the Relationship Between Hepatic Impairment and Myelosuppression (Decreased Bone Marrow Breast Cancer | — | 2024-08-19 |
| Completed | A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 Are Tolerated and Act in the B Healthy | Phase 1 | 2024-08-14 |
| Recruiting | Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib Alopecia Areata | — | 2024-08-07 |
| Completed | A Study to Learn About How a New Pneumococcal Vaccine Works in Children Pneumococcal Disease | Phase 2 | 2024-07-30 |
| Active Not Recruiting | Non Interventional Study to Investigate the Safety and Effectiveness in Patients With Relapsed and Refractory Relapsed and Refractory Multiple Myeloma (RRMM) | — | 2024-07-30 |
| Completed | To Learn How Different Forms of Study Medicine Are Taken up Into the Blood and the Effect of Food on Study Med Healthy | Phase 1 | 2024-07-29 |
| Active Not Recruiting | A Study to Learn About How a New Pneumococcal Vaccine Works in Infants Pneumococcal Disease | Phase 2 | 2024-07-25 |
| Completed | A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in W Breast Cancer | Phase 2 | 2024-07-11 |
| Completed | A Study to Learn How Different Forms of The Study Medicine Called Phenytoin Are Taken up Into the Blood in Hea Healthy | Phase 1 | 2024-07-03 |
| Completed | A Real-world, Prospective Observational Study of Rimegepant ODT for the Acute Treatment of Migraine Attacks in Migraine | — | 2024-07-02 |
| Active Not Recruiting | A Study to Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer. Lung Cancer | — | 2024-07-01 |
| Recruiting | Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry) Dermatitis, Atopic, Dermatitis, Eczema | — | 2024-07-01 |
| Recruiting | A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in Carcinoma, Pancreatic Ductal, Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung | Phase 1 | 2024-06-27 |
| Active Not Recruiting | A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer Breast Cancer, Malignant Neoplasm of Breast | — | 2024-06-24 |
| Completed | A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Ad Respiratory Syncytial Virus (RSV) | Phase 3 | 2024-06-24 |
| Active Not Recruiting | Korean Post-marketing Surveillance Ngenla® Pre-filled Pen Injection for the Treatment of Pediatric Patients Wi Pediatric Growth Hormone Deficiency | — | 2024-06-20 |
| Completed | Description of Relugolix Use in Patients With Prostate Cancer Within the VHA Prostate Cancer | — | 2024-06-19 |
| Completed | Real-World Effectiveness of High-Dose Tafamidis on Neurologic Disease Progression in Mixed-Phenotype Transthyr Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) | — | 2024-06-15 |
| Completed | A Study to Learn How the Study Medicine Called Zavegepant is Taken Up Into Blood and Breast Milk of Healthy Br Healthy | Phase 1 | 2024-06-10 |
| Completed | A Study to Learn About the Benefit of Rimegepant Versus Triptans in Migraine Buddy App Users. Migraine | — | 2024-06-09 |
| Terminated | A Study to Learn About the Adherence and Clinical Outcomes in Colombian Patients With an E-Device for Etanerce Rheumatoid Arthritis | — | 2024-06-06 |
| Completed | A Study About Modified RNA Vaccines Against Influenza in Healthy Adults Influenza, Human | Phase 2 | 2024-05-23 |
| Completed | A STUDY TO LEARN HOW THE STUDY MEDICINE CALLED PF-07293893 AFFECTS MUSCLE BIOMARKERS OF HEALTHY ADULTS Healthy Participants | Phase 1 | 2024-05-23 |
| Completed | A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic B Breast Neoplasms | — | 2024-05-20 |
| Completed | A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid Arthritis | — | 2024-05-15 |
| Completed | A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin Healthy | Phase 1 | 2024-05-13 |
| Terminated | A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combi Advanced or Metastatic Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer | Phase 1 | 2024-05-09 |
| Recruiting | A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis Colitis, Ulcerative | — | 2024-05-08 |
| Completed | A Study to Learn About How Different Forms of the Study Medicine Called Ritlecitinib Pass the Intestines of He Healthy Volunteers | Phase 1 | 2024-05-03 |
| Completed | A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss Liver Diseases | Phase 1 | 2024-04-30 |
| Completed | A Study to Learn How Different Forms of the Study Medicine Called PF-06954522 Are Taken up Into the Blood in H Healthy Participants | Phase 1 | 2024-04-30 |
| Recruiting | Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis Psoriatic Arthritis, Juvenile, Polyarticular Juvenile Idiopathic Arthritis | — | 2024-04-12 |
| Completed | A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Health Healthy | Phase 1 | 2024-04-02 |
| Withdrawn | A Study to Learn About the Patients With COVID-19 Prescribed Paxlovid in Morocco COVID-19 Drug Treatment | — | 2024-03-30 |
| Completed | A Study to Learn About Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) in India Transthyretin Amyloid Cardiomyopathy | — | 2024-03-25 |
| Completed | A Study to Learn About the Study Medicine Called Tafamidis 61mg in People Diagnosed With Transthyretin Amyloid Transthyretin Amyloid Cardiomyopathy | — | 2024-03-19 |
| Completed | A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain. COVID-19 | — | 2024-03-13 |
| Completed | A Study to Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants Respiratory Syncytial Virus | Phase 3 | 2024-03-12 |
| Completed | Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years SARS-CoV-2, COVID-19 | — | 2024-03-06 |
| Completed | A Study of HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inh Breast Cancer | — | 2024-03-06 |
| Unknown | A Study to Learn About the Dangers Linked to Myelosuppression (Decreased Bone Marrow Function) in Breast Cance Breast Cancer | — | 2024-03-01 |
| Active Not Recruiting | Litfulo Capsules Special Investigation Alopecia Areata | — | 2024-03-01 |
| Completed | A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults Healthy | Phase 1 | 2024-02-27 |
| Completed | A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Ve Healthy | Phase 1 | 2024-02-23 |
| Active Not Recruiting | ATGAM General Investigation Aplastic Anemia | — | 2024-02-21 |
| Recruiting | A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients Multiple Myeloma | Phase 1 | 2024-02-20 |
| Completed | A Study to Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mel Type 2 Diabetes Mellitus (T2DM), Obesity | Phase 1 | 2024-02-20 |
| Recruiting | A Study to Learn About the Study Medicine Zavicefta After it is Released Into the Markets in Korea Complicated Intra-abdominal Infection, Complicated Urinary Tract Infection, Hospital-acquired Pneumonia | — | 2024-02-19 |
| Active Not Recruiting | A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Breast Cancer | Phase 1 / Phase 2 | 2024-02-19 |
| Terminated | A Study to Learn About the Amount of the Study Medicine (Sisunatovir) in Blood and Its Safety in Infants and C Respiratory Syncytial Virus Infections | Phase 1 | 2024-02-15 |
| Recruiting | MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (M Multiple Myeloma | Phase 3 | 2024-02-08 |
| Terminated | A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors Neoplasms, Non-small-cell Lung Cancer, Melanoma | Phase 1 | 2024-02-08 |
| Completed | A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Med Healthy Participants | Phase 1 | 2024-02-08 |
| Completed | A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults Healthy Volunteers | Phase 1 | 2024-02-01 |
| Completed | A Study to Understand What the Body Does to the Study Medicine Called PF-07220060 When Taken by Healthy Adults Healthy Participants | Phase 1 | 2024-01-31 |
| Completed | A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults Influenza, Human, SARS-CoV-2 Infection, COVID-19 | Phase 2 | 2024-01-31 |
| Recruiting | A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitili Vitiligo | Phase 3 | 2024-01-19 |
| Withdrawn | A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza. COVID-19, Coronavirus Disease 2019, Influenza | — | 2024-01-17 |
| Completed | A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood i Healthy | Phase 1 | 2024-01-15 |
| Withdrawn | Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast C Breast Cancer, Ovarian Cancer, Liposarcoma | Phase 1 | 2024-01-15 |
| Active Not Recruiting | TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People Breast Cancer | Phase 1 / Phase 2 | 2024-01-10 |
| Active Not Recruiting | A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR Advanced or Metastatic Breast Cancer | Phase 2 | 2024-01-09 |
| Completed | Reliability of Rimegepant or Triptans for the Acute Treatment of Migraine Migraine Disorders | — | 2024-01-02 |
| Withdrawn | A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Pediatric Growth Hormone Deficiency | — | 2024-01-01 |
| Completed | A Study to Learn How the Body Processes Spironolactone and Hydrochlorothiazide Film Coated Tablets Manufacture Healthy Participants | Phase 1 | 2023-12-26 |
| Active Not Recruiting | A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults Pneumococcal Disease | Phase 1 / Phase 2 | 2023-12-20 |
| Completed | A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult Participants Healthy Participants | Phase 1 | 2023-12-20 |
| Completed | A Sub Study to Evaluate the Study Medication (Etrasimod) Using Wearable Sensors in Healthy Participants Healthy Participants | Phase 1 | 2023-12-20 |
| Completed | A Study to Learn How Safe, Tolerable and Capable of Producing an Immune Response is, a Modified RNA Vaccine Ag Grippe, Influenza, Vaccines | Phase 1 | 2023-12-13 |
| Terminated | A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infecti Respiratory Syncytial Virus Infection | Phase 2 / Phase 3 | 2023-12-08 |
| Recruiting | A Study To Learn About the Safety Medicine (Called Mylotarg) In People With Acute Myeloid Leukemia Acute Myeloid Leukemia | — | 2023-12-05 |
| Completed | A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] Arthritis, Rheumatoid, Colitis, Ulcerative, Crohn Disease | — | 2023-12-01 |
| Completed | A Study to Learn About Zavegepant as the Acute Treatment of Migraine in Asian Adults Migraine | Phase 3 | 2023-11-29 |
| Recruiting | A Study on Paxlovid Once in the Market, to Observe Its Safety and Effectiveness in Patients Who Have a High Ch COVID-19 | — | 2023-11-29 |
| Completed | Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Hea Healthy Participants, Healthy Subjects | Phase 1 | 2023-11-27 |
| Completed | A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volun Healthy | Phase 1 | 2023-11-23 |
| Completed | A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mC Prostatic Neoplasms | — | 2023-11-22 |
| Terminated | A Study to Learn How the Study Medicine PF-07899895 Are Tolerated and Act in the Body of Healthy Adults Healthy | Phase 1 | 2023-11-17 |
| Active Not Recruiting | A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmon Pulmonary Arterial Hypertension | Phase 1 / Phase 2 | 2023-11-17 |
| Active Not Recruiting | A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranqu Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo | Phase 3 | 2023-11-08 |
| Completed | A Phase 2 Study to Learn About a Monovalent Pneumococcal Conjugate Candidate in Healthy Toddlers Healthy Participants | Phase 2 | 2023-11-08 |
| Completed | A Study to Learn About Effects of Living With COVID-19 and the Use of the Medicines Nirmatrelvir-Ritonavir in COVID-19 | — | 2023-11-07 |
| Completed | A Study to Learn How a Medicine That Reduces Stomach Acid Affects the Level of Sisunatovir in the Blood of Hea Healthy | Phase 1 | 2023-11-03 |
| Completed | A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Heal Respiratory Syncytial Virus Infection | Phase 1 | 2023-11-03 |
| Active Not Recruiting | A Study to Learn About ABRYSVO Vaccine in Older Adults to Prevent Severe Respiratory Syncytial Virus (RSV) Dis Respiratory Syncytial Viruses | — | 2023-11-01 |
| Completed | A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Fu Renal Impairment | Phase 1 | 2023-10-30 |
| Completed | A Study to Learn How Different Amounts of the Study Medicine Called PF-07976016 Are Tolerated and Act in The B Healthy | Phase 1 | 2023-10-27 |
| Withdrawn | Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants Healthy | Phase 1 | 2023-10-25 |
| Completed | A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants Healthy | Phase 1 | 2023-10-23 |
| Active Not Recruiting | Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data SARS-CoV-2, COVID-19, Post-Acute COVID-19 Syndrome | — | 2023-10-23 |
| Completed | A Study to Learn About the Study Medicine - Precedex in Children From Japan. Sedation | — | 2023-10-18 |
| Completed | A Study of COVID-19 Patients Receiving Treatment With Nirmatrelvir; Ritonavir in the Kingdom of Saudi Arabia Covid-19 | — | 2023-10-17 |
| Completed | A Study to Understand the Use of Palbociclib in Canadian Patients With Breast Cancer That Has Spread to Other Breast Cancer | — | 2023-10-06 |
| Completed | A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer Prostatic Neoplasms | — | 2023-10-04 |
| Recruiting | Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) Multiple Myeloma | Phase 4 | 2023-10-03 |
| Completed | Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine C Breast Cancer | — | 2023-09-29 |
| Completed | A Study to Learn More About the Menopausal Hormone Therapies in Korea Menopause, Bone Demineralization | — | 2023-09-12 |
| Completed | Effectiveness of BNT162b2 Formulations Using State Vaccine Registry and Insurance Claims Data SARS-CoV-2, COVID-19 Vaccines | — | 2023-09-11 |
| Completed | A Study to Evaluate the Study Medication (Etrasimod) When Mixed With Food in Healthy Participants Healthy Participants | Phase 1 | 2023-09-04 |
| Completed | A Study to Compare the Effects of Elranatamab (PF 06863135) Versus Standard of Care (SOC) in Patients With Mul Multiple Myeloma | — | 2023-09-01 |
| Completed | A Retrospective Validation Study To Identify Chart-Based Clinical Diagnosis Of Wild-Type Transthyretin Amyloid ATTR-CM | — | 2023-09-01 |
| Completed | A Study to Compare Different Preparations of Sisunatovir in Healthy Adult Participants. Healthy | Phase 1 | 2023-09-01 |
| Active Not Recruiting | A Study to Learn About the Effects of Two Study Medicines (Maplirpacept [PF-07901801] And Glofitamab) When Giv Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | 2023-08-30 |
| Completed | A Study to Learn How Different Amounts of the Study Medicine Called PF-06954522 Are Tolerated and Act in the B Healthy Participants | Phase 1 | 2023-08-30 |
| Recruiting | A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis | Phase 2 | 2023-08-22 |
| Completed | A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants Healthy Participants | Phase 1 | 2023-08-18 |
| Completed | A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India. Pneumococcal Disease | Phase 3 | 2023-08-16 |
| Completed | Safety and Efficacy of Trastuzumab BS Gastric Cancer | — | 2023-08-09 |
| Completed | A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults Healthy Participants | Phase 1 | 2023-08-09 |
| Active Not Recruiting | Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Breast Cancer | Phase 3 | 2023-08-09 |
| Withdrawn | Voxelotor Brain Oxygenation and Neurocognitive Study Sickle Cell Disease | Phase 4 | 2023-08-09 |
| Terminated | Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diff Diffuse Large B-Cell Lymphoma | Phase 1 / Phase 2 | 2023-08-04 |
| Completed | A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Ad Healthy | Phase 1 | 2023-07-31 |
| Recruiting | A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring Atopic Dermatitis | — | 2023-07-25 |
| Completed | A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castr Prostatic Neoplasms, Castration-Resistant | — | 2023-07-24 |
| Completed | A Study to Compare How Effective is Encorafenib Plus Binimetinib in Real-world and Clinical Trial Settings Metastatic Melanoma | — | 2023-07-21 |
| Completed | A Study for Multiple Tablet Forms of The Study Medicine (PF-07220060) in Healthy Adults Healthy Participants | Phase 1 | 2023-07-11 |
| Completed | A Study to Compare Zavegepant Concentration Using Samples Collected From the Vein Versus Patient-Centric Micro Healthy | Phase 1 | 2023-07-10 |
| Terminated | A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. Lupus Erythematosus, Systemic, Lupus Erythematosus, Cutaneous | Phase 2 | 2023-07-07 |
| Completed | A Study to Learn About the Effects of Medicines That Help in Thinning the Blood in People With Atrial Fibrilla Atrial Fibrillation | — | 2023-07-07 |
| Terminated | Study of GBT021601 in Participants With Renal Impairment Renal Impairment | Phase 1 | 2023-06-29 |
| Completed | A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multi Non-Hodgkin Lymphoma, Multiple Myeloma | Phase 1 | 2023-06-28 |
| Completed | A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung C Non-Small Cell Lung Cancer | — | 2023-06-23 |
| Completed | A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age RESPIRATORY SYNCYTIAL VIRUS (RSV) | Phase 1 | 2023-06-22 |
| Completed | A Study to Learn About How Loss of Liver Function Affects the Blood Levels of the Study Medicine Called PF-078 COVID-19 | Phase 1 | 2023-06-15 |
| Terminated | A Study Comparing 3 Study Medicines (Encorafenib, Binimetinib, Pembrolizumab) to 2 Study Medicines (Ipilimumab Melanoma | Phase 2 | 2023-06-13 |
| Completed | A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults Healthy | Phase 1 | 2023-06-12 |
| Completed | A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who Are Healthy Volunteers C Pharmacokinetics, Healthy Volunteers | Phase 1 | 2023-06-09 |
| Completed | A Study to Compare How the Study Medicine (PF-07923568) is Processed in Participants With Different Levels of Liver Diseases, Hepatic Impairment | Phase 1 | 2023-06-07 |
| Completed | A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesse Healthy Participants | Phase 2 | 2023-06-05 |
| Completed | A Study to Learn About the Study Medicine PF-07853578 and How it Acts in the Bodies of Healthy Adults Healthy Participants | Phase 1 | 2023-06-02 |
| Completed | A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma | — | 2023-06-01 |
| Active Not Recruiting | A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Ce Relapse Multiple Myeloma, Refractory Multiple Myeloma | — | 2023-05-26 |
| Completed | A Study to Understand the Effect and Safety of the Study Medicine PF-07817883 in Adults Who Have Symptoms of C SARS-CoV-2 Infection | Phase 2 | 2023-05-23 |
| Recruiting | Post Marketing Surveillance(PMS) Study of Lorviqua in Korea Metastatic ALK+ Non Small Cell Lung Cancer | — | 2023-05-22 |
| Recruiting | A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myositis | Phase 3 | 2023-05-20 |
| Recruiting | A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) ACUTE LYMPHOBLASTIC LEUKEMIA | Phase 2 | 2023-05-17 |
| Completed | A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. Migraine | Phase 3 | 2023-05-15 |
| Completed | A Study to Investigate the Effects of Sisunatovir on QTc Interval in Healthy Adult Participants. Healthy | Phase 1 | 2023-05-15 |
| Completed | A Study to Assess the Safety, Tolerability, and Immunogenicity of RSVpreF in Adults at High Risk of Severe RSV RESPIRATORY SYNCYTIAL VIRUS (RSV) | Phase 3 | 2023-05-11 |
| Completed | A Study to Assess Two Forms of The Study Medicine (Ritlecitinib) in Healthy Adult Participants Healthy Volunteers, Adult, Pharmacokinetics | Phase 1 | 2023-05-09 |
| Completed | This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-1 Influenza, Human, COVID-19 | — | 2023-05-05 |
| Completed | A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adul Gonorrhea, Chlamydia, Meningococcal Vaccines | — | 2023-04-24 |
| Completed | A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance Pneumococcal Disease | Phase 1 | 2023-04-19 |
| Recruiting | Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative In Gram-negative Bacterial Infections | Phase 2 | 2023-04-18 |
| Completed | Voxelotor CYP and Transporter Cocktail Interaction Study Sickle Cell Disease | Phase 1 | 2023-04-17 |
| Completed | A Study to Learn About How Itraconazole Affects the Blood Level of Study Medicine (PF-07817883) in Healthy Adu Healthy | Phase 1 | 2023-04-13 |
| Completed | A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the B Healthy | Phase 1 | 2023-04-05 |
| Terminated | A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Healthy | Phase 1 | 2023-03-27 |
| Active Not Recruiting | To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Clostridoides Difficile Associated Disease | Phase 1 / Phase 2 | 2023-03-23 |
| Completed | A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV HIV, Pneumonia, Infections, Pneumococcal | — | 2023-03-22 |
| Completed | A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants. Healthy | Phase 1 | 2023-03-17 |
| Completed | A Study to Understand is the COVID-19 Vaccine BNT162b2 is Safe in Indonesia People COVID-19 | — | 2023-03-15 |
| Terminated | A Study to Understand the Long-term Safety and Effects of an Experimental Gene Therapy for Duchenne Muscular D Duchenne Muscular Dystrophy | Phase 3 | 2023-03-13 |
| Completed | Treatment Patterns Among Patients With Venous Thromboembolism in the United States Venous Thromboembolism | — | 2023-03-10 |
| Recruiting | A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis. Atopic Dermatitis, Eczema | — | 2023-03-09 |
| Terminated | A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Urinary Bladder Neoplasms, Bladder Cancer, Bladder Tumors | — | 2023-03-09 |
| Completed | A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Healthy | Phase 1 | 2023-03-09 |
| Completed | A Study of Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occu Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia | — | 2023-03-08 |
| Completed | A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transth Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype | — | 2023-03-08 |
| Active Not Recruiting | A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Advanced Breast Cancer | Phase 3 | 2023-03-03 |
| Completed | A Study to Learn About the Study Medicine (Called Ritlecitinib) For the Potential Treatment of Severe Alopecia Alopecia Areata | Phase 1 | 2023-03-02 |
| Active Not Recruiting | TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People Breast Cancer | Phase 1 / Phase 2 | 2023-03-01 |
| Completed | A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Acute Lymphoblastic Leukemia | Phase 4 | 2023-02-24 |
| Completed | A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy A Healthy | Phase 1 | 2023-02-23 |
| Active Not Recruiting | TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People Breast Cancer | Phase 1 / Phase 2 | 2023-02-23 |
| Completed | A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Receive Carcinoma, Renal Cell, Clear-cell Metastatic Renal Cell Carcinoma | — | 2023-02-23 |
| Completed | A Drug-Drug Interaction Study to Examine the Impact of Itraconazole and Cyclosporine on PF-07081532 Pharmacoki Healthy | Phase 1 | 2023-02-22 |
| Completed | A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Breast Cancer | Phase 1 | 2023-02-20 |
| Completed | Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland Metastatic Castration Sensitive Prostate Cancer (mCSPC), Metastatic Castration Resistant Prostate Cancer (mCRPC) | — | 2023-02-13 |
| Completed | A Study to Assess the Safety, Effects and Palatability of Sisunatovir in Healthy Adult Participants Respiratory Syncytial Viruses | Phase 1 | 2023-02-08 |
| Completed | Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi Invasive Fungal Disease | Phase 4 | 2023-02-07 |
| Active Not Recruiting | Ngenla Subcutaneous Injection Special Investigation Growth Hormone Deficiency Without Epiphyseal Closure | — | 2023-02-06 |
| Completed | A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults Healthy | Phase 1 | 2023-01-27 |
| Terminated | A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults Shingles, Herpes Zoster Infection, Human | Phase 1 / Phase 2 | 2023-01-25 |
| Terminated | A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Cont Obesity | Phase 1 | 2023-01-19 |
| Terminated | A Study to Learn About the Study Medicine Etrasimod in Adults With Moderate to Severe Atopic Dermatitis (AD) W Atopic Dermatitis, Atopic Dermatitis, Unspecified, Eczema | Phase 2 / Phase 3 | 2023-01-18 |
| Completed | A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese Overweight, Obesity | Phase 1 | 2023-01-18 |
| Terminated | A Study of Avelumab in Real-World Treatment for Patients With Advanced or Metastatic Urothelial Cancer Bladder Cancer | — | 2023-01-18 |
| Completed | A Study to Learn How the Study Medicine (Ponsegromab) is Changed and Eliminated From Healthy Chinese Adults Healthy | Phase 1 | 2023-01-18 |
| Recruiting | A Study to Learn About the Study Medicine (Called Cibinqo) in People With Atopic Dermatitis Dermatitis, Atopic | — | 2023-01-07 |
| Terminated | GBT021601-022: A Study of GBT021601 in Participants With Sickle Cell Disease (SCD) Sickle Cell Disease | Phase 2 / Phase 3 | 2023-01-05 |
| Recruiting | Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophili Hemophilia A, Hemophilia B | Phase 3 | 2022-12-28 |
| Completed | A GBT021601 ADME Microtracer Study in Healthy Volunteers Sickle Cell Disease | Phase 1 | 2022-12-22 |
| Completed | A Study to Understand How the Study Medicine (PF-07081532) is Processed and Eliminated in Healthy Men Healthy Participants | Phase 1 | 2022-12-21 |
| Recruiting | A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2022-12-16 |
| Active Not Recruiting | A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People Multiple Myeloma | Phase 1 | 2022-12-14 |
| Withdrawn | A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weak Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised | Phase 2 | 2022-12-13 |
| Completed | Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children Lyme Disease | Phase 3 | 2022-12-12 |
| Completed | A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women Healthy Participants | Phase 1 | 2022-12-12 |
| Completed | A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults Healthy | Phase 1 | 2022-12-09 |
| Recruiting | A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B Hemophilia A, Hemophilia B | Phase 3 | 2022-12-09 |
| Completed | A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo | Phase 3 | 2022-12-01 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With A Melanoma, Glioma, Thyroid Cancer | Phase 1 | 2022-11-30 |
| Completed | Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15 Non-small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer | Phase 2 | 2022-11-21 |
| Recruiting | A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years O Myocarditis | Phase 4 | 2022-11-21 |
| Completed | A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A R Arthritis, Rheumatoid | — | 2022-11-14 |
| Completed | This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Arthritis, Rheumatoid | — | 2022-11-11 |
| Recruiting | A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared Wi Multiple Myeloma | Phase 3 | 2022-11-10 |
| Completed | Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Re Migraine | Phase 4 | 2022-11-07 |
| Terminated | A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Trea Ulcerative Colitis | Phase 1 | 2022-11-07 |
| Completed | A Study to Learn About the Study Medicine (Called Maplirpacept (PF-07901801)) in Japanese With Hematologic Mal Lymphoma, Multiple Myeloma | Phase 1 | 2022-11-02 |
| Recruiting | A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting Pneumonia | — | 2022-10-27 |
| Terminated | Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separate Diabetes Mellitus, Obesity | Phase 2 | 2022-10-27 |
| Completed | Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Hereditary Transthyretin Amyloidosis (ATTRv), Polyneuropathy | — | 2022-10-24 |
| Terminated | Real-World Study of Ceftazidime Avibactam in China Hospital Acquired Pneumonia, Ventilator Acquired Pneumonia, Complicated Intra Abdominal Infections | — | 2022-10-20 |
| Completed | A Study to Learn About a Repeat 5-Day Treatment With the Study Medicines (Called Nirmatrelvir/Ritonavir) in Pe COVID-19 | Phase 2 | 2022-10-19 |
| Completed | A Study to Learn About Recifercept in Patients With Achondroplasia Achondroplasia | — | 2022-10-19 |
| Completed | Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan U Migraine | Phase 4 | 2022-10-18 |
| Completed | A First-in-human Study of Single Doses of PF-07328948 Which is Given to Healthy Adult Participants Healthy | Phase 1 | 2022-10-17 |
| Completed | A Study to Learn About Study Medicine Called PF-07261271 in Healthy People Healthy | Phase 1 | 2022-10-17 |
| Completed | A Study to Learn Safety and Blood Levels of PF-07817883 in Healthy People Healthy | Phase 1 | 2022-10-17 |
| Terminated | Treatment Patterns and Clinical Outcomes Among Patients With Advanced Renal Cell Carcinoma (aRCC) Receiving Sy Carcinoma, Renal Cell | — | 2022-10-15 |
| Completed | A Real-life Study to Learn About the Use and Effects of the CDK4/6 Inhibitors in Canadian Patients With Breast Breast Cancer | — | 2022-10-12 |
| Completed | Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in Peop Arthritis, Rheumatoid | — | 2022-10-10 |
| Completed | A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People. Healthy | Phase 1 | 2022-10-07 |
| Completed | A Study to Describe the Safety of a Vaccine (Called 13vPnC) in Healthy People 18 to 49 Years of Age in India Pneumococcal Disease | Phase 4 | 2022-10-06 |
| Completed | A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma Multiple Myeloma | — | 2022-10-03 |
| Completed | A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food Healthy | Phase 1 | 2022-09-29 |
| Completed | Relative Bioavailability Study of Nirmatrelvir/Ritonavir Oral Powder Relative to the Commercial Tablets and Es Biological Availability | Phase 1 | 2022-09-28 |
| Completed | A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Atopic Dermatitis, Plaque Psoriasis | Phase 2 | 2022-09-26 |
| Terminated | A Study of Ponsegromab in People With Heart Failure Heart Failure | Phase 2 | 2022-09-26 |
| Recruiting | A Phase 2/3 Study in Adult and Adolescent Participants With SCD Sickle Cell Disease | Phase 2 / Phase 3 | 2022-09-22 |
| Completed | A Study to Describe the Safety and Immunogenicity of 20vPnC in Infants in India and Taiwan Pneumococcal Disease | Phase 3 | 2022-09-16 |
| Completed | A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older Influenza, Human | Phase 3 | 2022-09-12 |
| Terminated | A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney COVID-19 | Phase 1 | 2022-09-07 |
| Completed | Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative t Biological Availability, Healthy Participants | Phase 1 | 2022-08-31 |
| Completed | A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism | — | 2022-08-31 |
| Completed | Enzalutamide vs. Abiraterone in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) Prostatic Neoplasms, Castration-Resistant | — | 2022-08-29 |
| Completed | A Study to Compare Two Tablet Forms of Tafamidis in Healthy Participants Healthy | Phase 1 | 2022-08-29 |
| Terminated | A Clinical Trial of the Study Medicine (PF-07081532) in People With Diabetes and Kidney Dysfunction Type 2 Diabetes, Renal Impairment | Phase 1 | 2022-08-29 |
| Completed | Safety and Effectiveness of Apixaban Compared to Warfarin in Patients With Non-valvular Atrial Fibrillation (a Non-valvular Atrial Fibrillation | — | 2022-08-25 |
| Completed | A Study to Learn About the Study Medication, Zavegepant, in Healthy Volunteers Biological Availability | Phase 1 | 2022-08-24 |
| Terminated | A Study to Evaluate AAV9 Neutralizing Antibody Seroconversion in Household Contacts. Household Contacts | — | 2022-08-17 |
| Active Not Recruiting | A Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or M Breast Neoplasms | Phase 1 | 2022-08-16 |
| Completed | A Preliminary Study to Evaluate PF-07264660 in Healthy Participants Healthy | Phase 1 | 2022-08-16 |
| Completed | Safety and Immunogenicity of Pneumococcal Conjugate Formulations in Healthy Adults 18 Through 49 Years of Age Pneumococcal Disease | Phase 1 | 2022-08-15 |
| Withdrawn | A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants Healthy Participants | Phase 1 | 2022-08-15 |
| Completed | Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine Group B Streptococcus Infections | Phase 2 | 2022-08-12 |
| Completed | Efficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only) Migraine | Phase 3 | 2022-08-09 |
| Completed | Efficacy and Safety Study of Rimegepant for the Acute Treatment of Migraine in Japanese Subjects (Japan Only) Migraine | Phase 3 | 2022-08-09 |
| Terminated | Study of Fordadistrogene Movaparvovec in Early Stage Duchenne Muscular Dystrophy Muscular Dystrophy, Duchenne | Phase 2 | 2022-08-08 |
| Completed | Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV) Respiratory Syncytial Virus (RSV) | Phase 1 | 2022-08-08 |
| Active Not Recruiting | An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease | Phase 3 | 2022-08-04 |
| Completed | A Study to Learn About the Study Medicines (Nirmatrelvir Plus Ritonavir) in People Aged 12 Years or Older With COVID-19 | Phase 2 | 2022-08-03 |
| Terminated | Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer Ovarian Cancer, Ovarian Neoplasms, Ovarian Carcinoma | Phase 1 / Phase 2 | 2022-08-01 |
| Completed | A Study to Understand How the Study Medicine (PF-07081532) is Processed in People With Liver Dysfunction Hepatic Impairment, Healthy Volunteers | Phase 1 | 2022-08-01 |
| Active Not Recruiting | High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France Atrial Fibrillation | — | 2022-08-01 |
| Completed | A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India Atopic Dermatitis | Phase 3 | 2022-07-16 |
| Recruiting | Korean Regulatory Post Marketing Surveillance for Somavert Acromegaly | — | 2022-07-13 |
| Active Not Recruiting | A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in Peo Metastatic Colorectal Cancer | Phase 2 | 2022-07-11 |
| Active Not Recruiting | Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies Breast Cancer, Head and Neck Cancer | Phase 2 | 2022-07-07 |
| Recruiting | A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Al Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer | Phase 1 | 2022-07-05 |
| Recruiting | The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Particip Solid Tumors | Phase 4 | 2022-07-05 |
| Completed | Non-interventional, Retrospective Cohort Study to Explore Antidepressant Treatment in Korea Major Depression | — | 2022-07-04 |
| Completed | Safety and Effectiveness of Apixaban in Very Elderly Patients With Non-valvular Atrial Fibrillation (NVAF) Com Non-valvular Atrial Fibrillation | — | 2022-07-01 |
| Completed | A Relative Bioavailability Study Evaluating Two New Encorafenib Formulations Healthy | Phase 1 | 2022-07-01 |
| Active Not Recruiting | Safety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002) Metastatic HER2+ Advanced Breast Cancer, Breast Neoplasms, Gastric or Gastroesophageal Junction Adenocarcinoma (GEC) | Phase 1 | 2022-06-29 |
| Completed | Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13 Pneumococcal Disease | Phase 3 | 2022-06-24 |
| Terminated | Voxelotor Neurocognitive Function Study Sickle Cell Disease | Phase 3 | 2022-06-24 |
| Terminated | A Study to Learn About the Study Medicine (Nirmatrelvir Plus Ritonavir) in Pregnant Women With COVID-19 COVID-19 | Phase 1 | 2022-06-22 |
| Completed | A Study to Learn About the First and Later Lines of Medicines in Treating People With Metastatic Renal Cell Ca Metastatic Renal Cell Carcinoma | — | 2022-06-20 |
| Completed | A Study to Understand the Effect of Low-Fat and High-Fat Meals on the Medicine Called PF-07284890 in Healthy A Healthy Participants | Phase 1 | 2022-06-17 |
| Completed | A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants Healthy | Phase 1 | 2022-06-10 |
| Completed | A Study to Learn How the Study Medicine Called PF-07275315 Works in Healthy People Healthy Volunteers | Phase 1 | 2022-06-09 |
| Completed | This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcer Ulcerative Colitis | — | 2022-05-30 |
| Terminated | Resolution of Sickle Cell Leg Ulcers With Voxelotor Sickle Cell Disease, Leg Ulcers | Phase 3 | 2022-05-30 |
| Completed | Outcomes Among Patients in Brazil Receiving Palbociclib Combinations for HR+/HER2- MBC Breast Cancer, Breast Carcinoma | — | 2022-05-30 |
| Completed | A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants Respiratory Syncytial Virus Infections | Phase 1 | 2022-05-25 |
| Completed | A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Parti Acute Migraine | Phase 3 | 2022-05-19 |
| Terminated | A Study to Learn About Abrocitinib in Adult Patients With Moderate to Severe Atopic Dermatitis Dermatitis, Atopic | — | 2022-05-10 |
| Terminated | Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandib Temporomandibular Disorders (TMD) | Phase 3 | 2022-05-05 |
| Completed | A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of So Renal Cell Cancer, Renal Cell Carcinoma, Cancer of Kidney | — | 2022-05-02 |
| Completed | A Study to Learn About the Study Medicine (Called Lorlatinib) in People With Liver Dysfunction Moderate Hepatic Impairment, Severe Hepatic Impairment, Healthy Volunteers | Phase 1 | 2022-04-28 |
| Completed | A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza, Human | Phase 1 | 2022-04-28 |
| Completed | Study to Evaluate Real-world Effectiveness With Palbociclib Plus Endocrine Therapy as First-line/Second-line T Breast Cancer | — | 2022-04-20 |
| Active Not Recruiting | A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis. Atopic Dermatitis | — | 2022-04-19 |
| Completed | Safety and Effectiveness of Apixaban Compared to Warfarin in Secondary Prevention in Patients With Atrial Fibr Non-valvular Atrial Fibrillation | — | 2022-04-15 |
| Completed | Safety and Immunogenicity of RSVpreF Coadministered With SIIV in Adults ≥65 Years of Age Respiratory Syncytial Virus | Phase 3 | 2022-04-13 |
| Completed | A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19 SARS-CoV-2 Infection | — | 2022-03-31 |
| Completed | A Study To Evaluate The Pharmacokinetics, Excretion, Mass Balance and Metabolism of PF-07265803 Healthy | Phase 1 | 2022-03-31 |
| Terminated | A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease | Phase 3 | 2022-03-29 |
| Terminated | Generate Real World Data On Tofacitinib Induction Therapy and Changes In Clinical and Patient Reported Outcome Ulcerative Colitis | — | 2022-03-28 |
| Active Not Recruiting | Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant Multiple Myeloma | Phase 3 | 2022-03-25 |
| Withdrawn | PF-07225570 Alone or in Combination With an Anti-PD-1 Antibody in Recurrent Non-muscle Invasive Bladder Cancer Bladder Cancer | Phase 1 | 2022-03-24 |
| Active Not Recruiting | Korea Comirnaty Post-marketing Surveillance COVID-19, Vaccines, Adverse Effects | — | 2022-03-18 |
| Completed | Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention Migraine, Episodic Migraine, Phonophobia | Phase 4 | 2022-03-15 |
| Active Not Recruiting | A Study to Learn About the Study Medicine (Called PF-07220060 in Combination With PF-07104091) In Participants Breast Cancer, Solid Tumors | Phase 1 / Phase 2 | 2022-03-14 |
| Completed | A Study to Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants. Healthy Participants | Phase 1 | 2022-03-10 |
| Completed | Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Heal Bioavailability | Phase 1 | 2022-03-10 |
| Recruiting | EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients U COVID-19 | Phase 3 | 2022-03-07 |
| Completed | Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens Migraine | Phase 4 | 2022-03-04 |
| Completed | Relative Bioavailability Study of 4 Different Formulations of PF-07321332 Relative to the Commercial Tablet Fo Bioavailability | Phase 1 | 2022-03-03 |
| Completed | A Study to Learn About The Study Medicine (Called PF-06823859) in Healthy Chinese Participants Healthy | Phase 1 | 2022-02-28 |
| Recruiting | Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects Migraine | Phase 3 | 2022-02-28 |
| Terminated | PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer | Phase 1 | 2022-02-24 |
| Withdrawn | Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participa Healthy Participants | Phase 1 | 2022-02-22 |
| Completed | Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic R Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps | Phase 3 | 2022-02-17 |
| Completed | Pharmacokinetic Comparability Study in Healthy Participants - PF-06881894 On-Body Injector Relative to Prefill Healthy Volunteers | Phase 1 | 2022-02-10 |
| Completed | A Study to Learn About Sickle Cell Disease In Adult Patients Sickle Cell Disease | — | 2022-02-10 |
| Completed | A First-in-human Study of Multiple Doses of Topically Administered PF-07295324 and PF-07259955 Healthy | Phase 1 | 2022-02-09 |
| Completed | European Treatment Patterns and Outcomes Associated With First-Line CDK4/6 Inhibition and Hormonal Therapies Metastatic Breast Cancer | — | 2022-02-08 |
| Terminated | Oxbryta® Product Registry An Observational Study Designed to Evaluate the Effect of Oxbryta in Individuals Wit Sickle Cell Disease | — | 2022-02-04 |
| Recruiting | Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia Primary Immune Thrombocytopenia | Phase 2 | 2022-02-02 |
| Completed | A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced o Breast Cancer | — | 2022-02-01 |
| Active Not Recruiting | A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza COVID-19, Coronavirus Disease 2019, Influenza | — | 2022-01-31 |
| Completed | Evaluation of the Relative Bioavailability of Bosutinib Capsules Under Fed Condition and Estimation of Food Ef Healthy Participants | Phase 1 | 2022-01-19 |
| Completed | Comparative Effectiveness of Targeted Therapies in BRAF Positive Metastatic Melanoma in the US Melanoma | — | 2022-01-17 |
| Terminated | Protonix Treatment of Maintenance of Healing in Pediatric Participants Aged 1-11 Years and 12-17 Years Esophagitis | Phase 2 | 2022-01-13 |
| Recruiting | Korean Post-marketing Surveillance for Xeljanz XR Active Moderate to Severe Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis | — | 2022-01-12 |
| Terminated | A Study to Assess the Hemodynamic Effects, Safety, Tolerability, and Pharmacokinetics of Intravenous APD418 in Acute Heart Failure With Reduced Ejection Fraction | Phase 2 | 2021-12-28 |
| Active Not Recruiting | Lorlatinib Continuation Study Non-Small-Cell Lung Cancer, NSCLC | Phase 4 | 2021-12-28 |
| Active Not Recruiting | Crizotinib Continuation Clinical Study NSCLC, ALCL, IMT | Phase 4 | 2021-12-27 |
| Terminated | Continuation Study of Long-term Safety, Tolerability, Pharmacokinetics and Efficacy of Recifercept in Achondro Achondroplasia | Phase 2 | 2021-12-24 |
| Completed | Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus Type 2 Diabetes Mellitus | Phase 1 | 2021-12-22 |
| Completed | A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma. Elranatamab, Myeloma, Multiple Myeloma | Phase 2 | 2021-12-21 |
| Completed | Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as Metastatic Breast Cancer | — | 2021-12-20 |
| Completed | An Extension Study for Participants Who Have Completed the Treatment Period of a Qualifying Parent Study Dermatomyositis | Phase 2 | 2021-12-20 |
| Completed | Treatment Patterns and Clinical Outcomes Among Talazoparib-Treated Adults With HER2-Negative mBC With gBRCA1/2 Metastatic Breast Cancer, Breast Neoplasms | — | 2021-12-17 |